ID 61901
Alternative Names: ID-61901Latest Information Update: 04 Feb 2021
Price :
$50 *
At a glance
- Originator Ildong Pharmaceutical
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 22 Jan 2021 ID 61901 is available for licensing as of 22 Jan 2021. https://www.ildong.com/eng/static/global/GL_003.id
- 22 Jan 2021 Early research in Solid tumours in South Korea (unspecified route) (Ildong Pharmaceutical pipeline, January 2021)